The possible association among breast cancer, diabetes mellitus and GLP-1 receptor

被引：0

作者：

Takigami, Naoko ^{[1
]}

Kuniyoshi, Shimpei ^{[2
]}

Miki, Yasuhiko ^{[2
]}

Tamaki, Kentaro ^{[1
]}

Kamada, Yoshihiko ^{[1
]}

Uehara, Kano ^{[1
]}

Tsuchiya, Seiko ^{[1
]}

Terukina, Shigeharu ^{[1
]}

Ishida, Takanori ^{[3
]}

Miyashita, Minoru ^{[3
]}

Kanai, Ayako ^{[3
]}

McNamara, Keely May ^{[2
]}

Tamaki, Nobumitsu ^{[1
]}

Sasano, Hironobu ^{[2
]}

机构：

[1] Nahanishi Clin, Okinawa, Japan

[2] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan

[3] Tohoku Univ, Grad Sch Med, Dept Breast & Endcrine Surg, Sendai, Miyagi, Japan

来源：

CANCER RESEARCH | 2020年 / 80卷 / 04期

关键词：

D O I：

10.1158/1538-7445.SABCS19-P3-02-10

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3-02-10

引用

页数：2

共 50 条

[21] Two New GLP-1 Receptor Agonists for Diabetes
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 109 - 111
[22] GLP-1 receptor agonists and heart failure in diabetes
Scheen, Andre J.
DIABETES & METABOLISM, 2017, 43 : 2S13 - 2S19
[23] GLP-1 receptor agonists for type 2 diabetes
De Block, Christophe E. M.
Van Gaal, Luc F.
LANCET, 2009, 374 (9683): : 4 - 6
[24] Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity
Kim, Won
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1496 - 1497
[25] GLP-1 receptor agonist for type 2 diabetes mellitus:an overview of systematic reviews/Metaanalysis
谢卓霖
ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (02) : 91 - 92
[26] GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents
Trujillo, Jennifer M.
Nuffer, Wesley
PHARMACOTHERAPY, 2014, 34 (11): : 1174 - 1186
[27] NUTRITIONAL INSULIN OR GLP-1 RECEPTOR AGONIST: CROSSROADS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Garg, Rajesh
ENDOCRINE PRACTICE, 2017, 23 (11) : 1357 - 1358
[28] Efficacy and Safety of GLP-1 Receptor Agonists Across the Spectrum of Type 2 Diabetes Mellitus
Leiter, Lawrence A.
Nauck, Michael A.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (07) : 419 - 435
[29] GLP-1 receptor agonists efficacy in managing comorbidities associated with diabetes mellitus: a narrative review
Mahshad Gholami
Narges Zargar Balajam
Samira Rakhsha
Sayed Mahmoud Sajjadi-Jazi
Gita Shafiee
Ramin Heshmat
Journal of Diabetes & Metabolic Disorders, 24 (1):
[30] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Verge, Danilo
Lopez, Ximena
CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200

← 1 2 3 4 5 →